Search Results - "Sia Wey, Yeo"

Characterization of Fatty Acid Binding Protein 7 (FABP7) in the Murine Retina by Su, Xinyi, Tan, Queenie S W, Parikh, Bhav H, Tan, Alison, Mehta, Milan N, Sia Wey, Yeo, Tun, Sai Bo Bo, Li, Ling-Jun, Han, Xiao-Yan, Wong, Tien Y, Hunziker, Walter, Luu, Chi D, Owada, Yuji, Barathi, Veluchamy A, Zhang, Samuel S, Chaurasia, Shyam S

“…To characterize the mouse retina lacking fatty acid binding protein (FABP7-/-). Immunohistochemistry (IHC) was performed in 8-week-old mice to localize FABP7…”
Get full text

The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy by Chaurasia, Shyam S., Lim, Rayne R., Parikh, Bhav H., Wey, Yeo Sia, Tun, Bo Bo, Wong, Tien Yin, Luu, Chi D., Agrawal, Rupesh, Ghosh, Arkasubhra, Mortellaro, Alessandra, Rackoczy, Elizabeth, Mohan, Rajiv R., Barathi, Veluchamy A.

“…Diabetic retinopathy (DR) is a retinal microvascular disease characterized by inflammatory and angiogenic pathways. In this study, we evaluated NLRP3…”
Get full text

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases by Regula, Jörg T, Lundh von Leithner, Peter, Foxton, Richard, Barathi, Veluchamy A, Cheung, Chui Ming Gemmy, Bo Tun, Sai Bo, Wey, Yeo Sia, Iwata, Daiju, Dostalek, Miroslav, Moelleken, Jörg, Stubenrauch, Kay G, Nogoceke, Everson, Widmer, Gabriella, Strassburger, Pamela, Koss, Michael J, Klein, Christian, Shima, David T, Hartmann, Guido

“…Anti‐angiogenic therapies using biological molecules that neutralize vascular endothelial growth factor‐A (VEGF‐A) have revolutionized treatment of retinal…”
Get full text

Gene-Based Therapeutics for Inherited Retinal Diseases by Fenner, Beau J, Tan, Tien-En, Barathi, Amutha Veluchamy, Tun, Sai Bo Bo, Yeo, Sia Wey, Tsai, Andrew S H, Lee, Shu Yen, Cheung, Chui Ming Gemmy, Chan, Choi Mun, Mehta, Jodhbir S, Teo, Kelvin Y C

“…Inherited retinal diseases (IRDs) are a heterogenous group of orphan eye diseases that typically result from monogenic mutations and are considered attractive…”
Get full text

HTRA1 Regulates Subclinical Inflammation and Activates Proangiogenic Response in the Retina and Choroid by Ahamed, Waseem, Yu, Richard Ming Chuan, Pan, Yang, Iwata, Takeshi, Barathi, Veluchamy Amutha, Wey, Yeo Sia, Tun, Sai Bo Bo, Qiu, Beiying, Tan, Alison, Wang, Xiaomeng, Cheung, Chui Ming Gemmy, Wong, Tien Yin, Yanagi, Yasuo

“…High-temperature requirement A1 (HtrA1) has been identified as a disease-susceptibility gene for age-related macular degeneration (AMD) including polypoidal…”
Get full text

Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and Progress by Tan, Tien-En, Fenner, Beau James, Barathi, Veluchamy Amutha, Tun, Sai Bo Bo, Wey, Yeo Sia, Tsai, Andrew Shih Hsiang, Su, Xinyi, Lee, Shu Yen, Cheung, Chui Ming Gemmy, Wong, Tien Yin, Mehta, Jodhbir Singh, Teo, Kelvin Yi Chong

“…Acquired retinal diseases such as age-related macular degeneration and diabetic retinopathy rank among the leading causes of blindness and visual loss…”
Get full text

Fluorescent Dye Labeling of Erythrocytes and Leukocytes for Studying the Flow Dynamics in Mouse Retinal Circulation by Agrawal, Rupesh, Balne, Praveen Kumar, Tun, Sai Bo Bo, Sia Wey, Yeo, Khandelwal, Neha, Barathi, Veluchamy A

“…The retinal and choroidal blood flow dynamics may provide insight into the pathophysiology and sequelae of various ocular diseases, such as glaucoma, diabetic…”
Get full text

Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases by Regula, Jörg T, Lundh von Leithner, Peter, Foxton, Richard, Barathi, Veluchamy A, Chui Ming, Gemmy Cheung, Tun, Sai Bo Bo, Wey, Yeo Sia, Iwata, Daiju, Dostalek, Miroslav, Moelleken, Jörg, Stubenrauch, Kay G, Nogoceke, Everson, Widmer, Gabriella, Strassburger, Pamela, Koss, Michael J, Klein, Christian, Shima, David T, Hartmann, Guido

“…In July 2017, the journal issued an editorial expression of concern (https://doi.org/10.15252/emmm.201707895) to alert readers that the data in Figs 4 and 5…”
Get full text

Moesin as a Key Cytoskeleton Regulator in Corneal Fibrosis by Zhu, Hong-Yuan, MD, Yeo, Sia-Wey, BS, Ng, Jennifer, BS, Htoon, Hla Myint, BDS, PhD, Beuerman, R.W., PhD

“…Abstract Purpose: Corneal fibrosis is the third leading cause of blindness worldwide. α-Smooth muscle actin (SMA), a marker of fibrosis, is closely regulated…”
Get full text

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases by Regula, Jörg T, Lundh von Leithner, Peter, Foxton, Richard, Barathi, Veluchamy A, Gemmy Cheung, Chui Ming, Bo Tun, Sai Bo, Wey, Yeo Sia, Iwata, Daiju, Dostalek, Miroslav, Moelleken, Jörg, Stubenrauch, Kay G, Nogoceke, Everson, Widmer, Gabriella, Strassburger, Pamela, Koss, Michael J, Klein, Christian, Shima, David T, Hartmann, Guido

Get full text

Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases by Regula, Jörg T, Lundh von Leithner, Peter, Foxton, Richard, Barathi, Veluchamy A, Cheung, Chui Ming Gemmy, Bo Tun, Sai Bo, Wey, Yeo Sia, Iwata, Daiju, Dostalek, Miroslav, Moelleken, Jörg, Stubenrauch, Kay G, Nogoceke, Everson, Widmer, Gabriella, Strassburger, Pamela, Koss, Michael J, Klein, Christian, Shima, David T, Hartmann, Guido

“…Anti‐angiogenic therapies using biological molecules that neutralize vascular endothelial growth factor‐A (VEGF‐A) have revolutionized treatment of retinal…”
Get full text

Potential of subconjunctival aflibercept in treating choroidal neovascularization by Nirmal, Jayabalan, Barathi, Veluchamy A., Dickescheid, Andreas, Wey, Yeo Sia, Nirmal, Sonali, Raja, Miguel Moreno, Venkatraman, Subbu, Agrawal, Rupesh

“…The study aimed to evaluate the intraocular pharmacokinetics and efficacy of aflibercept after subconjunctival injection in animal models for treating…”
Get full text

Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases by Regula, Jörg T, Lundh von Leithner, Peter, Foxton, Richard, Barathi, Veluchamy A, Chui Ming, Gemmy Cheung, Tun, Sai Bo Bo, Wey, Yeo Sia, Iwata, Daiju, Dostalek, Miroslav, Moelleken, Jörg, Stubenrauch, Kay G, Nogoceke, Everson, Widmer, Gabriella, Strassburger, Pamela, Koss, Michael J, Klein, Christian, Shima, David T, Hartmann, Guido

Get full text

Fluorescent Dye Labeling of Erythrocytes and Leukocytes for Studying the Flow Dynamics in Mouse Retinal Circulation by Agrawal, Rupesh, Balne, Praveen Kumar, Tun, Sai Bo Bo, Sia Wey, Yeo, Khandelwal, Neha, Barathi, Veluchamy A.

Get full text

Erratum To: Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases by Regula, Jörg T, Lundh von Leithner, Peter, Foxton, Richard, Barathi, Veluchamy A, Chui Ming, Gemmy Cheung, Tun, Sai Bo Bo, Wey, Yeo Sia, Iwata, Daiju, Dostalek, Miroslav, Moelleken, Jörg, Stubenrauch, Kay G, Nogoceke, Everson, Widmer, Gabriella, Strassburger, Pamela, Koss, Michael J, Klein, Christian, Shima, David T, Hartmann, Guido

“…Graphical Abstract…”
Get full text

A Minimally Invasive Experimental Model of Acute Ocular Hypertension with Acute Angle Closure Characteristics by Chong, Rachel S., Busoy, Joanna M. F., Tan, Bingyao, Yeo, Sia Wey, Lee, Ying Shi, Barathi, Amutha V., Crowston, Jonathan G., Schmetterer, Leopold

Get full text

A Minimally Invasive Experimental Model of Acute Ocular Hypertension with Acute Angle Closure Characteristics by Chong, Rachel S, Busoy, Joanna M F, Tan, Bingyao, Yeo, Sia Wey, Lee, Ying Shi, Barathi, Amutha V, Crowston, Jonathan G, Schmetterer, Leopold

“…To describe a minimally invasive experimental model of acute ocular hypertension (OHT) with characteristics of acute angle closure (AAC). Adult C57/Bl6 mice (n…”
Get full text

Targeting key angiogenic pathways with a bispecific Cross MA b optimized for neovascular eye diseases by Regula, Jörg T, Lundh von Leithner, Peter, Foxton, Richard, Barathi, Veluchamy A, Gemmy Cheung, Chui Ming, Bo Tun, Sai Bo, Wey, Yeo Sia, Iwata, Daiju, Dostalek, Miroslav, Moelleken, Jörg, Stubenrauch, Kay G, Nogoceke, Everson, Widmer, Gabriella, Strassburger, Pamela, Koss, Michael J, Klein, Christian, Shima, David T, Hartmann, Guido

Get full text

Erratum To: Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases by Regula, Jörg T, Lundh von Leithner, Peter, Foxton, Richard, Barathi, Veluchamy A, Gemmy Cheung, Chui Ming, Bo Tun, Sai Bo, Wey, Yeo Sia, Iwata, Daiju, Dostalek, Miroslav, Moelleken, Jörg, Stubenrauch, Kay G, Nogoceke, Everson, Widmer, Gabriella, Strassburger, Pamela, Koss, Michael J, Klein, Christian, Shima, David T, Hartmann, Guido

“…Graphical Abstract…”
Get full text